Gerber Kawasaki Wealth & Investment Management increased its position in shares of Baxter International Inc. (NYSE:BAX) by 0.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,675 shares of the company’s stock after buying an additional 65 shares during the period. Baxter International accounts for approximately 0.8% of Gerber Kawasaki Wealth & Investment Management’s investment portfolio, making the stock its 28th largest position. Gerber Kawasaki Wealth & Investment Management’s holdings in Baxter International were worth $1,206,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Trust Department MB Financial Bank N A raised its position in Baxter International by 4.1% in the second quarter. Trust Department MB Financial Bank N A now owns 1,746 shares of the company’s stock valued at $122,000 after buying an additional 68 shares during the period. Checchi Capital Advisers LLC raised its position in Baxter International by 1.9% in the second quarter. Checchi Capital Advisers LLC now owns 4,333 shares of the company’s stock valued at $196,000 after buying an additional 81 shares during the period. Private Trust Co. NA raised its position in Baxter International by 0.5% in the second quarter. Private Trust Co. NA now owns 29,036 shares of the company’s stock valued at $1,312,000 after buying an additional 144 shares during the period. iAB Financial Bank raised its position in Baxter International by 2.4% in the second quarter. iAB Financial Bank now owns 8,640 shares of the company’s stock valued at $391,000 after buying an additional 200 shares during the period. Finally, Stillwater Investment Management LLC raised its position in Baxter International by 3.3% in the second quarter. Stillwater Investment Management LLC now owns 19,379 shares of the company’s stock valued at $876,000 after buying an additional 611 shares during the period. Institutional investors and hedge funds own 84.38% of the company’s stock.
Baxter International Inc. (NYSE:BAX) traded down 0.15% during midday trading on Monday, hitting $47.38. 1,765,893 shares of the company traded hands. The stock’s 50-day moving average is $47.05 and its 200-day moving average is $45.57. Baxter International Inc. has a 12-month low of $33.78 and a 12-month high of $49.49. The firm has a market capitalization of $25.77 billion, a PE ratio of 5.44 and a beta of 0.70.
Baxter International (NYSE:BAX) last issued its earnings results on Tuesday, July 26th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.40 by $0.06. Baxter International had a net margin of 47.74% and a return on equity of 10.70%. The firm earned $2.60 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The business’s quarterly revenue was up 4.4% on a year-over-year basis. Analysts anticipate that Baxter International Inc. will post $1.73 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, October 3rd. Stockholders of record on Friday, September 2nd were given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.10%. The ex-dividend date was Wednesday, August 31st. Baxter International’s dividend payout ratio is 5.99%.
Several research analysts have issued reports on BAX shares. Wells Fargo & Co. started coverage on shares of Baxter International in a research report on Thursday. They issued an “outperform” rating on the stock. Zacks Investment Research lowered shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Thursday, October 6th. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Baxter International in a research note on Wednesday, July 6th. Argus reaffirmed a “hold” rating on shares of Baxter International in a research note on Monday, August 15th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Baxter International from $45.00 to $48.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 27th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $48.17.
About Baxter International
Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX).
Receive News & Ratings for Baxter International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.